CareLit · DOI-Nachweis · Pneumologie
The impact of time from diagnosis at baseline on long-term outcome in the GRIPHON Study: Selexipag in pulmonary arterial hypertension (PAH)
DOI 10.1055/s-0039-3403194
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Gaine, O Sitbon, R Channick, K Chin, L Di Scala, N Galie, MM Hoeper, V McLaughlin, R Preiss, L Rubin, G Simonneau, V Tapson, HA Ghofrani, I Lang
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
The impact of time from diagnosis at baseline on long-term outcome in the GRIPHON Study: Selexipag in pulmonary arterial hypertension (PAH)
Zitieren
Zitierempfehlung
S Gaine, O Sitbon, R Channick, K Chin, L Di Scala, N Galie, MM Hoeper, V McLaughlin, R Preiss, L Rubin, G Simonneau, V Tapson, HA Ghofrani, I Lang (2020) The impact of time from diagnosis at baseline on long-term outcome in the GRIPHON Study: Selexipag in pulmonary arterial hypertension (PAH). Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403194
Mit CareLit weiterarbeiten